Position in BBIO
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$95,479,644
+$13,019,757 QoQ
Shares Held
1,285,748
+19.3% QoQ
Ownership
0.656%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 58%
Shared 0%
None 42%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Derivatives in BBIO
reported options exposure · as of Jun 30, 2023CallValue
$0
CallShares
0
PutValue
$1,737,200
PutShares
101,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,750,242 across 347 Biotechnology names. BBIO ranks #18 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in BBIO
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $95,479,644 | 1,285,748 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $82,459,887 | 1,078,048 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $71,722,279 | 1,380,868 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $47,563,154 | 1,101,509 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $32,732,601 | 946,850 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $11,935,053 | 434,951 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $12,181,920 | 478,473 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $16,293,774 | 643,260 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $25,284,580 | 817,742 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $17,126,486 | 424,238 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $19,753,686 | 749,097 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,737,200 | 101,000 | Put | Defined | 2023-08-14 | |
| 2023-06-30 | $12,464,977 | 724,708 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $22,632,644 | 1,365,057 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $6,445,085 | 845,812 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $5,321,169 | 535,329 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,084,171 | 559,931 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $11,531,119 | 1,136,071 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $10,402,646 | 623,660 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $22,874,620 | 488,044 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $33,066,956 | 542,437 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $13,568,631 | 220,270 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $4,740,190 | 66,660 | Shares | Defined | 2021-02-10 | |
| 2020-12-31 | $1,592,864 | 22,400 | Call | Defined | 2021-02-10 | |
| 2020-09-30 | $1,381,786 | 36,828 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $720,028 | 22,080 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $593,311 | 20,459 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||